Trials / Unknown
UnknownNCT04097951
HDDO-1801 Intervention Trial
A Randomized, Open-label, Single-dose Study to Evaluate the Safety and the Pharmacokinetics After Oral Concurrent Administration of HDDO-18011 and HDDO-18012 in Healthy Adult Subjects
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- Hyundai Pharmaceutical Co., LTD. · Industry
- Sex
- Male
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
A randomized, open-label, single-dose, 3-period, 6-sequence, 3-way crossover study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Combinations | Montelukast and Bepotastine Combination |
Timeline
- Start date
- 2019-11-08
- Primary completion
- 2020-01-08
- Completion
- 2020-02-28
- First posted
- 2019-09-20
- Last updated
- 2019-09-20
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04097951. Inclusion in this directory is not an endorsement.